Hübner, Yannis R.
Spuck, Nikolai
Berger, Moritz
Schlabe, Stefan
Rieke, Gereon J.
Breitschwerdt, Sven
van Bremen, Kathrin
Strassburg, Christian P.
Gonzalez-Carmona, Maria A.
Wasmuth, Jan-Christian
Rockstroh, Jürgen K.
Boesecke, Christoph
Monin, Malte B.
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 22 May 2023
Accepted: 27 July 2023
First Online: 9 August 2023
Declarations
:
: Yannis R. Hübner declares on conflicts of interest. Nikolai Spuck declares on conflicts of interest. Moritz Berger declares on conflicts of interest. Stefan Schlabe had a stipend from the German Centre for Infectious Diseases Research (DZIF); he received congress fees and travel expenses from Gilead, Abbvie and Johnson&Johnson and funding from the German Research Society (DFG) for initiation of an African-German research project; he holds Fonds-based shares from BionTech.. Gereon J. Rieke declares on conflicts of interest. Sven Breitschwerdt declares on conflicts of interest. Kathrin van Bremen declares on conflicts of interest. Christian P. Strassburg declares on conflicts of interest. Maria A. Gonzalez-Carmona has contributed to advisory boards for Roche, Eisai. BMS, MSD and AZ. M.B.M. received travel expenses and honoraria from Gilead, Pfizer and Virology Education. Jan-Christian Wasmuth declares on conflicts of interest. Jürgen K. Rockstroh has received honoraria for lectures and/or consultancies from Abivax, Galapagos, Gilead, Merck, Janssen, Theratechnologies and ViiV. Christoph Boesecke received honoraria for lectures and/or consultancies from AbbVie, Gilead, Janssen, MSD, ViiV as well as funding from Dt. Leberstiftung, DZIF, Hector Stiftung, NEAT ID. Malte B. Monin received received honoraria for lectures, travel expenses and/or consultancies from Pfizer, Gilead Sciences, AstraZeneca, NovaVax and Virology Education. However, these activities have no potential conflicts of interest with the manuscript.
: The study was performed in accordance with the Declaration of Helsinki. Due to the retrospective study design, ethical approval and/or patient information was not required according to the North Rhine-Westphalian legislation.